E. Galani

发表

Carboplatin Hypersensitivity Reactions: A Single Institution Experience

E. Kastritis, C. Papadimitriou, E. Efstathiou, 2005, Journal of chemotherapy.

PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients

G. Aravantinos, H. Kalofonos, G. Fountzilas, 2015, Cancer Chemotherapy and Pharmacology.

Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.

P. Ellis, I. Smith, A. Ring, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients.

D. Bailey, C. Steer, P. Harper, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia.

G. Aravantinos, G. Fountzilas, G. Mountzios, 2016, Molecular and clinical oncology.

Performance status (PS): a simple predictor of short-term outcome of cancer patients with solid tumors admitted to the intensive care unit (ICU).

A. Michalopoulos, C. Christodoulou, E. Galani, 2007, Anticancer research.

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab

F. Fostira, A. Antonacopoulou, H. Kalofonos, 2011, The Pharmacogenomics Journal.

A Comprehensive Tumor Molecular Profile Analysis in Clinical Practice: A Single Center’s Experience

M. Özdoğan, I. Boukovinas, D. Trafalis, 2020 .

Quality of life: it's never too late.

D. Khayat, C. Steer, P. Harper, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study.

C. Steer, D. Yip, P. Harper, 2006, Gynecologic oncology.

Responses of human T cells to peptides flanking the tandem repeat and overlapping the signal sequence of MUC1

J. Burchell, J. Coleman, I. Correa, 2005, International journal of cancer.

Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein

M. Dimopoulos, D. Gika, A. Anagnostopoulos, 2004, Annals of Hematology.

Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature

C. Vrettou, I. Chatziralli, P. Theodossiadis, 2018, International Journal of Retina and Vitreous.

Correlation of in vitro cytotoxicity and clinical response to chemotherapy in ovarian and breast cancer patients.

N. Chondrogianni, E. Gonos, E. Samantas, 2001, Anticancer research.

Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone

M. Falagas, G. Klouvas, C. Christodoulou, 2009, Oncology.

Familial female and male germ cell cancer. A new syndrome?

M. Dimopoulos, C. Alamanis, E. Galani, 2005, Gynecologic oncology.

Long-term Survival of Patients with Breast Cancer and Brain Metastases: ‘The experience of the 2nd Oncology Department of Metropolitan Hospital and a brief review of the literature’

D. Skarlos, G. Klouvas, C. Christodoulou, 2015 .

Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.

E. Gonos, J. Sgouros, G. Aravantinos, 2002, Anticancer research.

Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study

A. Charchanti, H. Gogas, G. Aravantinos, 2022, Cancers.

Pseudomyxoma peritonei: the ‘controversial’ disease

C. Steer, P. Harper, E. Galani, 2003, International Journal of Gynecologic Cancer.

Small-cell lung cancer, high growth rate, high response rate to chemotherapy: ideal for high-dose chemotherapy?

P. Ellis, P. Harper, E. Galani, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Waldenström's macroglobulinemia.

M. Dimopoulos, S. Treon, G. Merlini, 1994, Hematology/oncology clinics of North America.

Human papilloma viruses and cancer in the post-vaccine era.

C. Christodoulou, E. Galani, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Can cetuximab affect paraneoplastic myopathy?

G. Klouvas, C. Christodoulou, E. Galani, 2009, Journal of Neuro-Oncology.

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

N. Pavlidis, S. Tejpar, G. Fountzilas, 2013, BMC Cancer.

Treatment of Waldenstrom's macroglobulinemia with thalidomide.

M. Dimopoulos, N. Viniou, P. Panayiotidis, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent M. tuberculosis, Klebsiella pneumoniae, and Candida albicans infection in liver metastasis of bowel carcinoma

M. Falagas, P. Rafailidis, C. Christodoulou, 2008, European Journal of Clinical Microbiology & Infectious Diseases.

Comprehensive tumor molecular profile analysis in clinical practice

M. Özdoğan, I. Boukovinas, D. Trafalis, 2021, BMC Medical Genomics.

The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.

Sabine Tejpar, George Fountzilas, George Kouvatseas, 2013, Clinical colorectal cancer.

Correlation of MDR 1 expression and CA 125 in ovarian cancer.

E. Gonos, M. Litos, J. Sgouros, 2005, In vivo.

Correlation of nm23-H1 gene expression with clinical outcome in patients with advanced breast cancer.

M. Belechri, E. Gonos, J. Sgouros, 2007, In vivo.

Thalidomide and dexamethasone combination for refractory multiple myeloma.

M. Dimopoulos, K. Zervas, C. Papadimitriou, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

P10. Effect of GFR methodology on carboplatin dosing

D. Bailey, C. Steer, G. Blake, 2002 .

Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group.

G. Fountzilas, A. Goussia, D. Skarlos, 2007, Anticancer research.

Pegfilgrastim Administered on the Same Day with Dose-Dense Adjuvant Chemotherapy for Breast Cancer Is Associated with a Higher Incidence of Febrile Neutropenia as Compared to Conventional Growth Factor Support: Matched Case-Control Study of the Hellenic Cooperative Oncology Group

G. Aravantinos, G. Fountzilas, G. Pentheroudakis, 2008, Oncology.

Treatment o f W aldenstrom's M acroglobulinemi a With T halidomide

M. Dimopoulos, N. Viniou, P. Panayiotidis, 2001 .

Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial.

U. Dafni, G. Fountzilas, N. Maniadakis, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention.

C. Christodoulou, E. Galani, G. Tsakalos, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials

H. Gogas, G. Aravantinos, A. Psyrri, 2015, Oncotarget.

Acute onset paraneoplastic cerebellar degeneration

S. Papageorgiou, E. Galani, N. Kalfakis, 2007, Journal of Neuro-Oncology.

Differential Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer Subtypes

H. Gogas, Anastasios Stofas, G. Fountzilas, 2014, PloS one.

Comprehensive tumor molecular profile analysis in clinical practice

M. Özdoğan, I. Boukovinas, D. Trafalis, 2021, BMC medical genomics.

Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based Regimens

K. Pavlakis, K. Papadopoulou, G. Fountzilas, 2021, Cancer research and treatment.

Immune Response Gene Expression in Colorectal Cancer Carries Distinct Prognostic Implications According to Tissue, Stage and Site: A Prospective Retrospective Translational Study in the Context of a Hellenic Cooperative Oncology Group Randomised Trial

K. Syrigos, R. Wirtz, G. Lazaridis, 2015, PloS one.

Non-small cell lung cancer in the elderly.

P. Harper, E. Galani, P. Makrantonakis, 2004, The oncologist.

1082O_PRWOMEN 4 ONCOLOGY IN GREECE: EXPLORING COMMON CHALLENGES- SURVEY OF THE HELLENIC SOCIETY OF MEDICAL ONCOLOGY AMONG WOMEN ONCOLOGY PROFESSIONALS

S. Agelaki, A. Psyrri, H. Linardou, 2014 .

Antioxidant Activity of Methyl Caffeate Enriched Olive Oils. From Extra Virgin Olive Oil to Extra Virgin Olive Oil‐Based Microemulsions

A. Xenakis, M. Chatzidaki, Demosthenes Fokas, 2022, European Journal of Lipid Science and Technology.

Human papilloma viruses and cancer in the post-vaccine era.

C. Christodoulou, E. Galani, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.

P. Ellis, I. Smith, A. Ring, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.